Bard Financial Services Inc. Has $5.58 Million Stock Holdings in Roche Holding AG $RHHBY

Bard Financial Services Inc. lessened its position in Roche Holding AG (OTCMKTS:RHHBY) by 1.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 136,850 shares of the company’s stock after selling 2,050 shares during the period. Bard Financial Services Inc.’s holdings in Roche were worth $5,578,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Altrius Capital Management Inc lifted its position in Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock worth $7,818,000 after buying an additional 6,545 shares in the last quarter. Everett Harris & Co. CA acquired a new position in Roche during the 1st quarter worth about $445,000. Rhumbline Advisers lifted its position in Roche by 7.4% during the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock worth $4,413,000 after buying an additional 7,374 shares in the last quarter. Riverbridge Partners LLC lifted its position in Roche by 6.7% during the 1st quarter. Riverbridge Partners LLC now owns 37,826 shares of the company’s stock worth $1,557,000 after buying an additional 2,381 shares in the last quarter. Finally, Moloney Securities Asset Management LLC lifted its position in Roche by 53.8% during the 1st quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company’s stock worth $1,672,000 after buying an additional 14,245 shares in the last quarter.

Roche Stock Performance

Shares of OTCMKTS RHHBY opened at $41.35 on Monday. The firm’s 50-day simple moving average is $40.33 and its 200 day simple moving average is $40.35. The company has a current ratio of 1.48, a quick ratio of 1.20 and a debt-to-equity ratio of 0.85. Roche Holding AG has a 12-month low of $34.10 and a 12-month high of $44.31.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.